Insight

$Rahul Banerjee: Fascinating small Ph2 trial on relapsed or refractory multiple myeloma$

Jul 3, 2024, 02:35

Rahul Banerjee: Fascinating small Ph2 trial on relapsed or refractory multiple myeloma

Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X:

“Absolutely abscopal responses …. in myeloma??

Fascinating small Ph2 trial in The Lancet Haematology by Khan Sagar Lonial et al:

Pembro q3wk + 1 Fx RT to EMD sites… 7/25 responders, inc. 2 CRs. Better than I might’ve guessed for pembro monoTx in multiple myeloma.”

$Rahul Banerjee: Fascinating small Ph2 trial on relapsed or refractory multiple myeloma$

Read further.
Source: Rahul Banerjee/X

abscopal responses Assistant professor cancer complete response EMD sites immunotherapy Khan Sagar Lonial multiple myeloma Myeloma OncoDaily Oncology oncology research pembrolizumab phase 2 trial radiotherapy Rahul Banerjee The Lancet Haematology UW Medicine

Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage